Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €6.92 EUR
Change Today -0.075 / -1.07%
Volume 17.5K
FDA On Other Exchanges
Symbol
Exchange
Berlin
BrsaItaliana
As of 11:30 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

fidia spa (FDA) Snapshot

Open
€6.95
Previous Close
€6.99
Day High
€6.96
Day Low
€6.72
52 Week High
04/1/15 - €9.66
52 Week Low
10/16/14 - €2.60
Market Cap
35.4M
Average Volume 10 Days
31.2K
EPS TTM
€1.02
Shares Outstanding
5.1M
EX-Date
05/11/15
P/E TM
6.8x
Dividend
€0.25
Dividend Yield
3.62%
Current Stock Chart for FIDIA SPA (FDA)

Related News

No related news articles were found.

fidia spa (FDA) Related Businessweek News

No Related Businessweek News Found

fidia spa (FDA) Details

Fidia S.p.A. manufactures and sells numerical controls and software, and high-speed milling systems. It also offers milling heads; and technical support, training, and field services. The company also provides accessories, including head/table measuring and calibration device systems; tool length, diameter, and shape measurement laser devices; tracers for surface scanning; portable pushbutton panels with handwheel; digital drives; and I/O modules. In addition, it offers software products, such as ViMill, a 3D simulator; HI-MILL, a 3D cam software; Isograph, a 2D ½ CAD/CAM product for on board programming; VAC, a volumetric compensation software; and ACM OMATIVE for adaptive control. The company has operations in Italy, Europe, Asia, North and South America, and internationally. Fidia S.p.A. was founded in 1974 and is headquartered in San Mauro Torinese, Italy.

Founded in 1974

fidia spa (FDA) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

fidia spa (FDA) Key Developments

FIDIA SpA Reports Consolidated Earnings Results for the Six Months Ended June 30, 2015

FIDIA SpA reported consolidated earnings results for the six months ended June 30, 2015. For the period, the company’s net revenues were €28,807,000 against €19,214,000 a year ago. EBITDA was €2,742,000 against LBITDA of €1,171,000 a year ago. EBIT was €1,778,000 against LBIT of €1,285,000 a year ago. Income before taxes was €1,154,000 against Loss before taxes of €1,396,000 a year ago. Net income for the accounting period was €711,000 against net loss for the accounting period of €1,560,000 a year ago. Income attributable to the group was €873,000 against loss attributable to the group of €1,410,000 a year ago. Cash used in operating activities during the accounting period was €1,304,000 against €498,000 a year ago.

Fidia S.p.A Reports Consolidated Earnings Results for the First Quarter Ended March 31, 2015

Fidia S.p.A. reported consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported net revenues of EUR 6,528,000 against EUR 6,899,000 for the same period a year ago. The decrease of the turnover has involved only the High Speed Milling Machines sector. Negative gross operating margin (EBITDA) was EUR 1,512,000 against EUR 1,344,000 for the same period a year ago. Negative operating margin (EBIT) was EUR 1,752,000 against EUR 1,544,000 for the same period a year ago. Loss before taxes was EUR 2,262,000 against EUR 1,526,000 for the same period a year ago. Loss attributable to the group was EUR 2,063,000 against EUR 1,513,000 for the same period a year ago. Cash used in operating activities was EUR 6,257,000 against EUR 2,402,000 for the same period a year ago. The decrease of the turnover has involved only the High Speed Milling Machines sector. The net financial position of the group is a credit by EUR 490,000, compared to a debit by EUR 690,000 as at March 31, 2014 and to a credit by EUR 5,031,000 as at December 31, 2014.

FIDIA SpA Reports Unaudited Consolidated and Draft Financial Statement Earnings Results for the Year Ended December 31, 2014

FIDIA SpA reported unaudited consolidated and draft financial statement earnings results for the year ended December 31, 2014. For the year on consolidated basis, the company reported net revenues of EUR 54.544 million against EUR 44.704 million a year ago. Gross operating margin (EBITDA) was EUR 4.982 million against EUR 27 million a year ago. Operating margin (EBIT) was EUR 4.324 million against LBIT of EUR 986 million a year ago. Margin before taxes (EBT) was EUR 3.511 million against LBT of EUR 1.240 million a year ago. Net income for the accounting period was EUR 2.774 million against net loss for the accounting period of EUR 1.567 million a year ago. Cash from operating activities during the period was EUR 4.773 million against EUR 2.762 million a year ago. For the year on draft financial statement, the company reported net revenues of EUR 42.822 million against EUR 35.872 million a year ago. Gross operating margin (EBITDA) was EUR 1.894 million against LBITDA of EUR 1.610 million a year ago. Operating margin (EBIT) was EUR 2.692 million against LBIT of EUR 2.277 million a year ago. Margin before taxes (EBT) was EUR 3.532 million against LBT of EUR 1.149 million a year ago. Net income for the accounting period was EUR 3.019 million against net loss for the accounting period of EUR 1.348 million a year ago. Cash from operating activities during the period was EUR 5.060 million against EUR 3.676 million a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FDA:IM €6.92 EUR -0.075

FDA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FDA.
View Industry Companies
 

Industry Analysis

FDA

Industry Average

Valuation FDA Industry Range
Price/Earnings 7.0x
Price/Sales 0.6x
Price/Book 2.5x
Price/Cash Flow 5.6x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FIDIA SPA, please visit www.fidia.it. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.